Sorry for interrupting, this website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Learn more
Accept & Close

Gastrointestinal Remedies: Digestive and Immunity Health - US - April 2010

The market for over the counter (OTC) gastrointestinal (GI) remedies performed strongly in 2009, driven by the shift of prescription brands to OTC availability. However, most brands are losing ground to private label competition, and there is question as to whether new launches will truly result in incremental sales. A new class of product threatens to take the focus away from occasional OTC remedies in favor of regular dietary supplements.

In this report, Mintel takes a look at the state of the GI remedy market and explains why certain brand strategies are working and others are not. Consumer behavior toward GI remedies is examined for ways to increase sales.

Analysis and insights offered in this report include:

  • Which OTC brands are managing to grow sales while most are slipping
  • Which new launches are anticipated to drive future growth
  • How the probiotic trend is expanding the category
  • Who marketers are targeting and how
  • What fears lie behind a resistance to taking OTC remedies
  • Which GI problems drive the most consumers to purchase remedies
  • Which factors are more important than price when selecting a remedy
  • What percentage of consumers actually consult with medical professionals about their GI issues

What you get

What's included

Why buy from us?

Succeed

Our reports will provide you with market data, consumer research and competitive intelligence to succeed in your market.

Instant Access

Buy now and you'll have instant access to the information you need to make the right decisions.

Opportunities

Find out what's next in the markets that matter to you: where opportunities lie and what challenges you will face.

Trusted

A business Superbrand, Mintel is a source you can trust. We have been defining and refining the Market Intelligence mix since 1972.

Table of contents

  1. Scope and Themes

    • What you need to know
      • Definition
        • Data sources
          • Sales data
            • Consumer survey data
              • Advertising creative
                • Abbreviations and terms
                  • Abbreviations
                    • Terms
                    • Executive Summary

                      • Incremental sales from Rx-to-OTC launches expected to diminish
                        • Recession drives behavioral shift toward store brands
                          • Popularity of OTC remedies is second only to inaction
                            • Probiotics offer natural solution with added benefits
                              • Drug channel extends share against food and mass outlets
                                • Recent new launch campaigns use emotional appeal and female targeting
                                  • Most respondents ignore or self-diagnose digestive problems
                                    • Younger consumers represent larger potential consumer base
                                      • Search for relief drives the most consumers to OTC
                                        • Majority of respondents are open to new brands but many are loyal to private label
                                          • Speed of action and other factors more important than price during purchase
                                            • Significant minority concerned about longer term effects
                                              • Women more likely to experience most GI ailments
                                                • Black and Hispanic consumers respond more to ads and price promotions
                                                • Insights and Opportunities

                                                  • Align as an OTC remedy paves the way for worry-free daily dosage
                                                    • Younger consumers may respond better to remedies marketed as food
                                                    • Inspire Insights

                                                        • Trend: Extend My Brand
                                                          • What it’s about
                                                            • Blurring lines in digestive health
                                                              • The ultimate solution
                                                              • Market Size and Forecast

                                                                • Key points
                                                                  • GI remedies keep pace with overall OTC market thanks to new product launches
                                                                    • Sales and forecast of gastrointestinal remedies
                                                                      • Figure 1: FDMx retail sales and forecast of gastrointestinal remedies, at current prices, 2004-14
                                                                      • Figure 2: FDMx retail sales and forecast of gastrointestinal remedies, at inflation-adjusted prices, 2004-14
                                                                    • Walmart sales
                                                                    • Competitive Context

                                                                      • Popularity of OTC remedies is second only to inaction
                                                                        • Figure 3: Treatments sought for gastrointestinal problems, January 2010
                                                                      • Consumers show preference for more natural solutions to GI problems
                                                                          • Figure 4: Attitudes toward diet and digestive health, January 2010
                                                                        • Immunity benefits give probiotics another selling point to branch out of GI remedy market
                                                                        • Natural Channel sales for Digestive Health

                                                                            • Sales of digestive aids in the natural channel
                                                                                • Figure 5: Natural supermarket sales of digestive aids, at current prices, 2008-10
                                                                                • Figure 6: Natural supermarket sales of digestive aids, at inflation-adjusted prices, 2008-10
                                                                              • Natural channel sales by segment
                                                                                • Figure 7: Natural supermarket sales of digestive aids, by segment, 2008 and 2010
                                                                              • Natural channel digestive aid brand sales
                                                                                  • Figure 8: Manufacturer natural supermarket sales of digestive aids, 2008 and 2010
                                                                              • Segment Performance

                                                                                • Key points
                                                                                  • Segment performance reflects new product launches
                                                                                    • Sales of gastrointestinal remedies, by segment
                                                                                      • Figure 9: FDMx sales of gastrointestinal remedies, segmented by type, 2008 and 2009
                                                                                  • Segment Performance—Antacids

                                                                                    • Key points
                                                                                      • Antacid sales rebound with new OTC launch
                                                                                        • Figure 10: FDMx sales of antacids, at current prices, 2004-14
                                                                                    • Segment Performance—Laxatives

                                                                                      • Key points
                                                                                        • Laxatives continue to ride off the impact of Miralax
                                                                                          • Sales and forecast of laxatives
                                                                                            • Figure 11: FDMx sales of laxatives, at current prices, 2004-14
                                                                                        • Segment Performance—Stomach Remedies

                                                                                          • Key points
                                                                                            • Stomach remedies surge with Align launch
                                                                                              • Sales and forecast of stomach remedies
                                                                                                • Figure 12: FDMx sales of stomach remedies, at current prices, 2004-14
                                                                                            • Segment Performance—Anti-Diarrheals

                                                                                              • Key points
                                                                                                • Anti-diarrheals suffer from lack of new products
                                                                                                  • Sales and forecast of anti-diarrheals
                                                                                                    • Figure 13: FDMx sales of anti-diarrheals, at current prices, 2004-14
                                                                                                • Retail Channels

                                                                                                  • Key points
                                                                                                    • Drug channel extends share against food and mass outlets
                                                                                                      • Sales of gastrointestinal remedies, by channel
                                                                                                        • Figure 14: FDMx sales of gastrointestinal remedies, by channel, 2008 and 2009
                                                                                                    • Retail Channels—Drug Stores

                                                                                                      • Key points
                                                                                                        • Drug store channel warrants premium with greater perception of trust
                                                                                                          • Drug stores attract private label shoppers and triple their margin
                                                                                                            • Drug store sales of gastrointestinal remedies
                                                                                                              • Figure 15: U.S. drug store sales of gastrointestinal remedies, at current prices, 2004-09
                                                                                                          • Retail Channels—Other FDMx

                                                                                                            • Key points
                                                                                                              • Growth at food and mass lags behind overall market
                                                                                                                • Other IRI channel sales of gastrointestinal remedies
                                                                                                                  • Figure 16: U.S. other IRI channel sales of gastrointestinal remedies, at current prices, 2004-09
                                                                                                              • Market Drivers

                                                                                                                • Incremental sales from Rx-to-OTC launches expected to diminish
                                                                                                                  • Economic hardship drives behavioral shift toward store brands
                                                                                                                      • Figure 17: Indexed FDMx sales of private label vs. total digestive health products, 2004-09
                                                                                                                    • Consumers over 45 are overrepresented in consumer base
                                                                                                                      • Figure 18: Population aged 18 or older, 2005-15
                                                                                                                    • Obesity linked to heartburn with irreversible damage
                                                                                                                      • Figure 19: Age-adjusted prevalence of overweight and obesity among U.S. adults aged 20+, 1988-2006
                                                                                                                    • Consumers adopt daily regimen to fight GI problems
                                                                                                                    • Leading Companies

                                                                                                                      • Key points
                                                                                                                        • Brand marketers lose more ground to private label in a tough economy
                                                                                                                          • Branded growth comes from new products coming off prescription
                                                                                                                            • Manufacturer sales of gastrointestinal remedies
                                                                                                                              • Figure 20: FDMx sales of leading gastrointestinal remedies companies, rolling 52 weeks, ending January 25, 2009 and January 24, 2010
                                                                                                                          • Brand Share—Antacids

                                                                                                                            • Key points
                                                                                                                              • Private label growth comes at the expense of Rx-to-OTC switchers
                                                                                                                                • Prevacid offers direct branded competition for Prilosec
                                                                                                                                  • Over the counter PPI space to get even more crowded in 2010
                                                                                                                                    • Negative drug interaction may hinder sales of Prilosec in 2010
                                                                                                                                      • Manufacturer and brand sales antacids
                                                                                                                                        • Figure 21: Selected brand sales and market share of antacids in the U.S., rolling 52 weeks, ending January 25, 2009 and January 24, 2010
                                                                                                                                    • Brand Share—Laxatives

                                                                                                                                      • Key points
                                                                                                                                        • Miralax momentum continues but faces new private label challenge
                                                                                                                                          • Benefiber outperforms fiber competitors with sexy marketing
                                                                                                                                            • Manufacturer and brand sales of laxatives
                                                                                                                                              • Figure 22: Selected brand sales and market share of laxatives in the U.S., rolling 52 weeks, ending January 25, 2009 and January 24, 2010
                                                                                                                                          • Brand Share—Stomach Remedies

                                                                                                                                            • Key points
                                                                                                                                              • Retail launch of Align boosts segment with incremental sales
                                                                                                                                                • Manufacturer and brand sales of stomach remedies
                                                                                                                                                  • Figure 23: Selected brand sales and market share of stomach remedies in the U.S., rolling 52 weeks, ending January 25, 2009 and January 24, 2010
                                                                                                                                              • Brand Share—Anti-Diarrheals

                                                                                                                                                • Key points
                                                                                                                                                  • Anti-diarrheal sales decline due to lack of innovation
                                                                                                                                                    • Manufacturer and brand sales of anti-diarrheals
                                                                                                                                                      • Figure 24: Selected brand sales and market share of anti-diarrheals in the U.S., rolling 52 weeks, ending January 25, 2009 and January 24, 2010
                                                                                                                                                  • Innovation and Innovators

                                                                                                                                                    • Probiotic products generate continued interest
                                                                                                                                                      • Colon cleansing trend presents alternative digestive maintenance
                                                                                                                                                        • Focus on women
                                                                                                                                                        • Brands and the Advertising Landscape

                                                                                                                                                          • Ad spend sees steep cuts but newer brands keep growing
                                                                                                                                                            • Figure 25: Media expenditures for selected GI remedy brands from Brandweek’s 2009 Superbrands report, 2007-08
                                                                                                                                                          • Prevacid: Strong differentiation needed in the suddenly crowded PPI space
                                                                                                                                                            • Prevacid 24HR launch
                                                                                                                                                              • Figure 26: Prevacid 24HR—Comedy Club, November 2009
                                                                                                                                                            • Other antacids
                                                                                                                                                              • Figure 27: Pepcid Complete—Works Now or Later, December 2009
                                                                                                                                                            • Miralax: A laxative made stylish for women
                                                                                                                                                                • Figure 28: Miralax—Natural Rhythm, 2009
                                                                                                                                                              • Other brands
                                                                                                                                                                • Figure 29: Dulcolax—Feeling Free, July 2009
                                                                                                                                                            • Digestive Health Issues

                                                                                                                                                              • Key points
                                                                                                                                                                • Tapping into younger consumers could grow sales
                                                                                                                                                                  • Figure 30: Frequency of digestive health issues, by age, January 2010
                                                                                                                                                                • Most respondents ignore or self-diagnose digestive problems
                                                                                                                                                                  • Figure 31: Medical professionals consulted regarding digestive health, January 2010
                                                                                                                                                                • Youngest respondents (18-24) are least likely to seek medical advice
                                                                                                                                                                  • Figure 32: Medical professionals consulted regarding digestive health, by age, January 2010
                                                                                                                                                              • Digestive Health Remedies and Treatment

                                                                                                                                                                • Key points
                                                                                                                                                                  • Heartburn, acid reflux, or stomach ulcer drive the most consumers to OTC
                                                                                                                                                                    • Figure 33: Treatments sought for gastrointestinal problems—OTC and prescription, January 2010
                                                                                                                                                                  • Immediate pain or inconvenience may drive respondents to seek OTC treatment
                                                                                                                                                                    • Figure 34: Treatments sought for gastrointestinal problems—natural and nothing, January 2010
                                                                                                                                                                  • Regular consumption drives more frequent purchase of antacids
                                                                                                                                                                    • Figure 35: OTC gastrointestinal products purchased, January 2010
                                                                                                                                                                  • Under-35s are less likely buyers of most OTC GI products
                                                                                                                                                                    • Figure 36: OTC gastrointestinal products purchased, by age, January 2010
                                                                                                                                                                • Purchase Decisions

                                                                                                                                                                  • Key points
                                                                                                                                                                    • Majority of respondents are open to new brands; a quarter buy private label
                                                                                                                                                                      • At least a third of respondents self-diagnose; small minority decide just on price
                                                                                                                                                                        • Figure 37: Gastrointestinal remedy purchasing habits, January 2010
                                                                                                                                                                      • Respondents 18-24 most likely to buy on sale
                                                                                                                                                                        • Figure 38: Gastrointestinal remedy purchasing habits, by age, January 2010
                                                                                                                                                                      • Doctor’s recommendation more important as respondents age
                                                                                                                                                                        • Figure 39: Sources of gastrointestinal remedy information, by age, January 2010
                                                                                                                                                                    • Selection Factors

                                                                                                                                                                      • Key points
                                                                                                                                                                        • Faster action is most compelling selection factor; brand name among the least
                                                                                                                                                                          • Figure 40: Importance of key factors when selecting gastrointestinal remedies, January 2010
                                                                                                                                                                        • Price becomes less of a factor over the age of 45
                                                                                                                                                                          • Figure 41: Importance of key factors when selecting gastrointestinal remedies, by age, January 2010
                                                                                                                                                                      • New Product Trial

                                                                                                                                                                        • Key points
                                                                                                                                                                          • Ads and coupons see more impact among 25-34 year olds
                                                                                                                                                                            • Figure 42: Gastrointestinal remedy product trial, by age, January 2010
                                                                                                                                                                          • Brand switchers looking for faster acting products and fewer side effects
                                                                                                                                                                            • Figure 43: Reasons to try new gastrointestinal remedy products, January 2010
                                                                                                                                                                          • Boomer respondents more interested in on-the-go use
                                                                                                                                                                            • Figure 44: Reasons to try new gastrointestinal remedy products, by age, January 2010
                                                                                                                                                                        • Attitudes and Concerns

                                                                                                                                                                          • Key points
                                                                                                                                                                            • Significant minority concerned about longer term effects
                                                                                                                                                                              • Figure 45: Attitudes toward gastrointestinal remedies, by type of remedy, January 2010
                                                                                                                                                                            • Over 55s more likely to keep OTC remedies on hand
                                                                                                                                                                              • Figure 46: Attitudes toward OTC gastrointestinal remedies, by age, January 2010
                                                                                                                                                                          • Marketing to Women

                                                                                                                                                                            • Key points
                                                                                                                                                                              • Overview
                                                                                                                                                                                • Women more likely to experience most GI ailments
                                                                                                                                                                                  • Figure 47: Incidence of gastrointestinal problems, by gender, January 2010
                                                                                                                                                                                • Women more likely to self-diagnose
                                                                                                                                                                                  • Figure 48: Medical professionals consulted regarding digestive health, by gender, January 2010
                                                                                                                                                                                  • Figure 49: Gastrointestinal remedy purchasing habits, by gender, January 2010
                                                                                                                                                                                • Women are more demanding of OTC remedies and less brand loyal
                                                                                                                                                                                  • Figure 50: Importance of key factors when selecting gastrointestinal remedies, by gender, January 2010
                                                                                                                                                                                  • Figure 51: Laxative forms of gastrointestinal remedies used, by gender, April 2008-June 2009
                                                                                                                                                                                • Marketing to women is an effective point of differentiation
                                                                                                                                                                                  • Figure 52: OTC gastrointestinal remedy products purchased, by gender, January 2010
                                                                                                                                                                                • Brands can show female skew but still attract men
                                                                                                                                                                                  • Figure 53: Popularity of selected OTC heartburn/indigestion brands, by gender, April 2008-June 2009
                                                                                                                                                                                  • Figure 54: Popularity of selected OTC laxative brands, by gender, April 2008-June 2009
                                                                                                                                                                              • Impact of Race and Hispanic Origin

                                                                                                                                                                                • Key points
                                                                                                                                                                                  • Black respondents are less likely to seek out OTC GI remedies
                                                                                                                                                                                    • Figure 55: Incidence of gastrointestinal problems, by race/Hispanic origin, January 2010
                                                                                                                                                                                    • Figure 56: Usage of OTC remedies for gastrointestinal problems, by race/Hispanic origin, January 2010
                                                                                                                                                                                  • Black and Hispanics more likely to respond to price discounts
                                                                                                                                                                                    • Figure 57: Gastrointestinal remedy purchasing habits, by race/Hispanic origin, January 2010
                                                                                                                                                                                  • Black and Hispanics more responsive to advertising
                                                                                                                                                                                    • Figure 58: Gastrointestinal remedy product trial, by race/Hispanic origin, January 2010
                                                                                                                                                                                  • Blacks and Hispanics more fearful of negative effects
                                                                                                                                                                                    • Figure 59: Attitudes toward OTC gastrointestinal remedies, by race/Hispanic origin, January 2010
                                                                                                                                                                                • Cluster Analysis

                                                                                                                                                                                    • Product Optimizers
                                                                                                                                                                                      • Who they are
                                                                                                                                                                                        • Opportunity
                                                                                                                                                                                          • Proactive Managers
                                                                                                                                                                                            • Who they are
                                                                                                                                                                                              • Opportunity
                                                                                                                                                                                                • Steadfast and Satisfied
                                                                                                                                                                                                  • Who they are
                                                                                                                                                                                                    • Opportunity
                                                                                                                                                                                                      • Cluster characteristics
                                                                                                                                                                                                        • Figure 60: Digestive and immunity health clusters, January 2010
                                                                                                                                                                                                        • Figure 61: Sources of gastrointestinal remedy information, purchasing habits and product trial, by digestive and immunity health clusters, January 2010
                                                                                                                                                                                                        • Figure 62: Importance of factors when selecting gastrointestinal remedies, by digestive and immunity health clusters, January 2010
                                                                                                                                                                                                        • Figure 63: Attitudes toward diet and digestive health, by digestive and immunity health clusters, January 2010
                                                                                                                                                                                                        • Figure 64: Reasons to try new gastrointestinal remedy products, by digestive and immunity health clusters, January 2010
                                                                                                                                                                                                      • Cluster demographics
                                                                                                                                                                                                        • Figure 65: Digestive and immunity health clusters, by gender, January 2010
                                                                                                                                                                                                        • Figure 66: Digestive and immunity health clusters, by age, January 2010
                                                                                                                                                                                                        • Figure 67: Digestive and immunity health clusters, by household income, January 2010
                                                                                                                                                                                                        • Figure 68: Digestive and immunity health clusters by race/Hispanic origin, January 2010
                                                                                                                                                                                                      • Cluster methodology
                                                                                                                                                                                                      • Custom Consumer Groups

                                                                                                                                                                                                        • Gender gap for certain GI problems changes with age
                                                                                                                                                                                                            • Figure 69: Incidence of gastrointestinal problems, by age and gender, January 2010
                                                                                                                                                                                                          • Women under 35 are least likely to seek medical advice
                                                                                                                                                                                                              • Figure 70: Medical professionals consulted regarding digestive health, by age and gender, January 2010
                                                                                                                                                                                                              • Figure 71: Gastrointestinal remedy purchasing habits, by age and gender, January 2010
                                                                                                                                                                                                            • Women under 35 represent the most untapped potential
                                                                                                                                                                                                                • Figure 72: Lack of treatment for gastrointestinal problems, by age and gender, January 2010
                                                                                                                                                                                                            • IRI/Builders Panel Data

                                                                                                                                                                                                                • Overview of gastrointestinal tablets and liquids
                                                                                                                                                                                                                  • Antacids
                                                                                                                                                                                                                    • Consumer insights on key purchase measures
                                                                                                                                                                                                                      • Brand map—tablets
                                                                                                                                                                                                                        • Figure 73: Brand map, selected brands of antacid tablets, buying rate by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                      • Brand leader characteristics—tablets
                                                                                                                                                                                                                        • Key purchase measures—tablets
                                                                                                                                                                                                                          • Figure 74: Key purchase measures for the top brands of antacid tablets, by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                        • Brand map—liquids
                                                                                                                                                                                                                          • Figure 75: Brand map, selected brands of antacid liquid/powder, buying rate by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                        • Brand leader characteristics—liquids
                                                                                                                                                                                                                          • Key purchase measures—liquids
                                                                                                                                                                                                                            • Figure 76: Key purchase measures for the top brands of antacid liquid/powder, by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                          • Laxatives
                                                                                                                                                                                                                            • Consumer insights on key purchase measures
                                                                                                                                                                                                                              • Brand map—tablets
                                                                                                                                                                                                                                • Figure 77: Brand map, selected brands of laxative tablets, buying rate by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                              • Brand leader characteristics—tablets
                                                                                                                                                                                                                                • Key purchase measures—tablets
                                                                                                                                                                                                                                  • Figure 78: Key purchase measures for the top brands of laxative tablets, by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                                • Brand map—liquid/powder/oils
                                                                                                                                                                                                                                  • Figure 79: Brand map, selected brands of laxative/stimulant liquid/powder/oil, buying rate by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                                • Brand leader characteristics—liquid/powder/oils
                                                                                                                                                                                                                                  • Key purchase measures—liquid/powder/oils
                                                                                                                                                                                                                                    • Figure 80: Key purchase measures for the top brands of laxative/stimulant liquid/powder/oil, by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                                  • Stomach remedy liquid/powder
                                                                                                                                                                                                                                    • Consumer insights on key purchase measures
                                                                                                                                                                                                                                      • Brand map
                                                                                                                                                                                                                                        • Figure 81: Brand map, selected brands of stomach remedy liquid/powder, buying rate by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                                      • Brand leader characteristics
                                                                                                                                                                                                                                        • Key purchase measures
                                                                                                                                                                                                                                          • Figure 82: Key purchase measures for the top brands of stomach remedy liquid/powder, by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                                        • Diarrhea liquid medicine/powder
                                                                                                                                                                                                                                          • Consumer insights on key purchase measures
                                                                                                                                                                                                                                            • Brand map
                                                                                                                                                                                                                                              • Figure 83: Brand map, selected brands of diarrhea liquid medicine/powder, buying rate by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                                            • Brand leader characteristics
                                                                                                                                                                                                                                              • Key purchase measures
                                                                                                                                                                                                                                                • Figure 84: Key purchase measures for the top brands of diarrhea liquid medicine/powder, by household penetration, 52 weeks ending June 28, 2009
                                                                                                                                                                                                                                            • Appendix: Other Useful Consumer Tables

                                                                                                                                                                                                                                                • Figure 85: Reasons to try new gastrointestinal remedy products, by gender, January 2010
                                                                                                                                                                                                                                                • Figure 86: Heartburn/indigestion aid forms used, by gender, April 2008-June 2009
                                                                                                                                                                                                                                            • Appendix: IRI/Builders Panel Data Definitions

                                                                                                                                                                                                                                                • IRI Consumer Network Metrics
                                                                                                                                                                                                                                                • Appendix: Trade Associations

                                                                                                                                                                                                                                                  Companies Covered

                                                                                                                                                                                                                                                  • American College of Gastroenterology (ACG)
                                                                                                                                                                                                                                                  • American Gastroenterological Association (AGA)
                                                                                                                                                                                                                                                  • American Pharmacists Association (APhA)
                                                                                                                                                                                                                                                  • Boehringer Ingelheim Pharmaceuticals, Inc.
                                                                                                                                                                                                                                                  • Consumer Healthcare Products Association (CHPA)
                                                                                                                                                                                                                                                  • Food and Drug Administration
                                                                                                                                                                                                                                                  • GlaxoSmithKline (USA)
                                                                                                                                                                                                                                                  • Greenfield Online
                                                                                                                                                                                                                                                  • Johnson & Johnson
                                                                                                                                                                                                                                                  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
                                                                                                                                                                                                                                                  • Novartis AG
                                                                                                                                                                                                                                                  • Nutraceutical Corporation
                                                                                                                                                                                                                                                  • Procter & Gamble USA
                                                                                                                                                                                                                                                  • Schering-Plough Corporation
                                                                                                                                                                                                                                                  • Target Corporation
                                                                                                                                                                                                                                                  • The Kroger Co.
                                                                                                                                                                                                                                                  • U.S. Bureau of Labor Statistics
                                                                                                                                                                                                                                                  • Walmart Stores (USA)
                                                                                                                                                                                                                                                  • Whole Foods Market Inc
                                                                                                                                                                                                                                                  • YouTube, Inc.

                                                                                                                                                                                                                                                  Gastrointestinal Remedies: Digestive and Immunity Health - US - April 2010

                                                                                                                                                                                                                                                  US $3,995.00 (Excl.Tax)